Antiretrovirals for the heavily experienced patient: hefty plans to holidays
- PMID: 11366942
Item in Clipboard
Antiretrovirals for the heavily experienced patient: hefty plans to holidays
Res Initiat Treat Action.
1999 Oct.
Abstract
AIDS: When seeking alternative therapies for treatment-experienced patients, several issues must be addressed. Considerations for various therapies include determining what is an acceptable level of viral load to be achieved, and how many drugs should be used in combination regimens. Clinical data supporting these approaches are detailed. To provide effective treatments for experienced patients, pharmaceutical companies should design drugs that differ considerably from current drugs, which are achieving positive results mainly in treatment-naive populations. A glossary of terms used in the article is provided.
Similar articles
-
Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Verh K Acad Geneeskd Belg. 2001. PMID: 11813503 Review.
-
Resistance testing debate: does it make the grade?Res Initiat Treat Action. 1999 Oct;5(4):9-12. Res Initiat Treat Action. 1999. PMID: 11366943
-
Abacavir for salvage or intensification.GMHC Treat Issues. 1999 Jan;13(1):4-5. GMHC Treat Issues. 1999. PMID: 11366111
-
New antiretroviral tactics: transitions or mere trends? An interview with Joep Lange,MD,PhD. Interview by Mark Mascolini.J Int Assoc Physicians AIDS Care. 1999 Jul;5(7):25-9. J Int Assoc Physicians AIDS Care. 1999. PMID: 11367133
-
Challenges for the clinical development of new nucleoside reverse transcriptase inhibitors for HIV infection.Antivir Ther. 2005;10(1):13-28. Antivir Ther. 2005. PMID: 15751760 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical